Home Healthcare Medical Devices Alpha Emitter Market

Alpha Emitter Market Size, Share & Trends Analysis Report By Type of Radionuclide (Astatine-211, Radium-223, Actinium-225, Lead-212, Bismuth-212, Other Radionuclides), By Application (Prostate Cancer, Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, Other Applications), By End User (Hospitals, Diagnostic Centers, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 13, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR3555DR | Pages: 140
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
  7. North America Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
  8. Europe Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    7. France
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
  9. APAC Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    5. China
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    8. India
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
  10. Middle East and Africa Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
  11. LATAM Alpha Emitter Market Size Analysis
    1. Introduction
    2. Alpha Emitter Market Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
      1. Astatine-211
      2. Radium-223
      3. Actinium-225
      4. Lead-212
      5. Bismuth-212
      6. Other Radionuclides
    3. Alpha Emitter Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Bone Metastasis
      3. Ovarian Cancer
      4. Pancreatic Cancer
      5. Endocrine Tumors
      6. Other Applications
    4. Alpha Emitter Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type of Radionuclide 2022-2034 (USD MILLION/ Units)
        1. Astatine-211
        2. Radium-223
        3. Actinium-225
        4. Lead-212
        5. Bismuth-212
        6. Other Radionuclides
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Bone Metastasis
        3. Ovarian Cancer
        4. Pancreatic Cancer
        5. Endocrine Tumors
        6. Other Applications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Other End Users
  12. Competitive Landscape
    1. Alpha Emitter Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Bayer AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis AG
    3. Actinium Pharmaceuticals Inc.
    4. Alpha Fusion
    5. Fusion Pharmaceuticals Inc.
    6. Telix Pharmaceuticals Ltd
    7. Alpha Tau Medical Ltd
    8. IBA Radiopharma Solutions
    9. RadioMedix Inc.
    10. Orano Med SAS
    11. Curium Pharma
    12. BWXT Medical Ltd
    13. Cardinal Health Inc.
    14. Eckert & Ziegler
    15. ITM Isotopen Technologien Mnchen SE
    16. Nucleus RadioPharma
    17. ARTBIO
    18. Cyclotek Australia Pty Ltd
    19. SHINE Technologies LLC
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.